These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28417267)

  • 21. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
    Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
    Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preemptive Dose Adjustment Effect on the Quality of Anticoagulation Management in Warfarin Patients With Drug Interactions: A Retrospective Cohort Study.
    Fahmi AM; Mohamed A; Elewa H; Saad MO
    Clin Appl Thromb Hemost; 2019; 25():1076029619872554. PubMed ID: 31482725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.
    Lane MA; Zeringue A; McDonald JR
    Am J Med; 2014 Jul; 127(7):657-663.e2. PubMed ID: 24657899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin.
    Beckey NP; Parra D; Colon A
    Pharmacotherapy; 2000 Sep; 20(9):1055-9. PubMed ID: 10999497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants.
    Clark NP; Hoang K; Delate T; Horn JR; Witt DM
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):172-178. PubMed ID: 28118749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
    Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
    J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged international normalized ratio during the first year of warfarin treatment.
    Bergman M; Dicker D; Blumberger N; Brener ZZ; Ori Y; Salman H
    Am J Med Sci; 2014 Jul; 348(1):71-4. PubMed ID: 24949726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
    McCall KL; Scott JC; Anderson HG
    Pharmacotherapy; 2005 Jan; 25(1):67-73. PubMed ID: 15767222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the safety and efficacy of warfarin in Taiwanese patients.
    Kuo LN; Liou JP; Chen HY; Chiang YC; Wu MT
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):106-13. PubMed ID: 23351596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally Administered Trimethoprim-Sulfamethoxazole and Metronidazole as Infection Prophylaxis in Elective Colorectal Surgery.
    Hjalmarsson C; Karlberg J; Törnqvist P; Arbman G; Frisk B; Modin M;
    Surg Infect (Larchmt); 2015 Oct; 16(5):604-10. PubMed ID: 26125945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Impact of Setting a Narrow International Normalized Ratio Target Range in the Management of Older Adult Patients on Warfarin.
    Ong PY; Koomanan N; Cheen MH; Lai YF; Lim SH; Kong MC; Ng HJ
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):528-34. PubMed ID: 26239317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with warfarin in Chinese population.
    Chenhsu RY; Chiang SC; Chou MH; Lin MF
    Ann Pharmacother; 2000 Dec; 34(12):1395-401. PubMed ID: 11144695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.